A novel skin substitute called the Biodegradable Temporizing Matrix, will take the next development steps under a three-year, $8.2 million contract with PolyNovo Limited of Port Melbourne, Australia ...
PERTH, Australia – On the heels of scoring a CE mark for its Novosorb biodegradable temporizing matrix (BTM) in the EU, Melbourne-based Polynovo Ltd. crossed its first AU$2 million (US$1.3 million) ...
Polynovo Ltd. engages in the development of medical devices, utilizing the patented polymer technology NovoSorb. It focuses on biodegradable temporizing matrix (BTM) product. It operates through the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results